triazoles has been researched along with Diffuse Large B-Cell Lymphoma in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.45) | 18.7374 |
| 1990's | 1 (3.23) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (41.94) | 24.3611 |
| 2020's | 15 (48.39) | 2.80 |
| Authors | Studies |
|---|---|
| Bakhshi, S; Caimi, PF; Canales, M; Casasnovas, RO; Cavallo, F; Chamoun, K; Choquet, S; Egyed, M; Follows, G; Goy, A; Gurion, R; Hamad, N; Hill, B; Jaeger, U; Kalakonda, N; Kauffman, MG; Ku, M; Kuruvilla, J; la Cruz, F; Ma, X; Maerevoet, M; Neste, EVD; Offner, F; Samal, P; Sancho, JM; Schuster, M; Shacham, S; Shah, J; Thieblemont, C; Vassilakopoulos, TP; Vermaat, JSP; Warzocha, K; Zijlstra, JM | 1 |
| Chavez, JC; Logue, JM | 1 |
| Bakhshi, S; Caimi, P; Canales, M; Casasnovas, RO; Cavallo, F; Chamoun, K; Choquet, S; Corona, K; De la Cruz, F; Egyed, M; Follows, G; Goy, A; Gurion, R; Hamad, N; Hill, B; Jaeger, U; Kalakonda, N; Kauffman, MG; Ku, M; Kuruvilla, J; Ma, X; Maerevoet, M; Neste, EVD; Offner, F; Samal, P; Sancho, JM; Schuster, M; Shacham, S; Shah, J; Thieblemont, C; Vassilakopoulos, T; Vermaat, JSP; Warzocha, K; Zijlstra, J | 1 |
| Sylvain, C | 1 |
| Baker, S; Bhat, S; Byrd, JC; Canfield, D; Cempre, CB; Fu, Q; Hu, B; Huang, Y; Jaglowski, SM; Lapalombella, R; Lockman, H; Rogers, KA; Ruppert, AS; Shah, H; Stephens, DM; Vadeboncoeur, R; Walker, JS; Woyach, JA | 1 |
| Ben-Barouch, S; Kuruvilla, J | 1 |
| Chiappella, A; Corradini, P | 1 |
| Bakhshi, S; Bouabdallah, R; Canales, MA; Casasnovas, O; Cavallo, F; Chang, H; Choquet, S; Corona, K; De la Cruz, F; Egyed, M; Follows, G; Goy, A; Gurion, R; Hamad, N; Hill, B; Jaeger, U; Joshi, A; Kalakonda, N; Kauffman, M; Landesman, Y; Ma, X; Maerevoet, M; McCarthy, D; Mishra, S; Offner, F; Saint-Martin, JR; Sancho, JM; Schuster, M; Shacham, S; Shah, J; Thieblemont, C; Van Den Neste, E; Vassilakopoulos, TP; Vermaat, JSP; Wang, H; Warzocha, K; Zijlstra, JM | 1 |
| Gopal, AK; Smith, SD | 1 |
| Kalakonda, N; Kauffman, M; Shah, J | 1 |
| Azmi, AS; Mohammad, RM; Uddin, MH | 1 |
| Harris, LJ; Martin, M; Patel, K | 1 |
| Bader, JC; Li, H; Shacham, S; Shah, J; Tang, S; Wada, R; Xu, H | 1 |
| Gormley, NJ; Kasamon, YL; Li, RJ; Ma, L; Okusanya, OO; Pazdur, R; Price, LSL; Richardson, NC; Theoret, M; Wu, YT | 1 |
| Bakhshi, S; Caimi, P; Canales, M; Casasnovas, RO; Cavallo, F; Chamoun, K; Choquet, S; Corona, K; De la Cruz, F; Egyed, M; Follows, G; Goy, A; Gurion, R; Hamad, N; Hill, B; Jaeger, U; Kalakonda, N; Kauffman, MG; Ku, M; Kuruvilla, J; Ma, X; Maerevoet, M; Offner, F; Samal, P; Sancho, JM; Schuster, M; Shacham, S; Shah, J; Thieblemont, C; Van Den Neste, E; Vassilakopoulos, TP; Vermaat, JSP; Warzocha, K; Zijlstra, JM | 1 |
| Bazargan, A; Chai, KL; Kostos, L; Tam, CS | 1 |
| Abrisqueta, P; Bobillo, S; Bosch, F; Carpio, C; Castellví, J; Crespo, M; Raheja, P | 1 |
| Aboukameel, A; Al-Katib, A; Azmi, AS; Kauffman, M; McCauley, D; Mohammad, RM; Shacham, S | 1 |
| Bradner, JE; Chapuy, B; Doench, JG; Kung, AL; Lin, CY; McKeown, MR; Monti, S; Qi, J; Rahl, PB; Reichert, E; Rodig, SJ; Roemer, MG; Shipp, MA; Sun, HH; Yeda, KT; Young, RA | 1 |
| Bradner, JE; Evens, AM; Gerstein, RM; Greiner, DL; Shultz, LD; Trabucco, SE; Zhang, H | 1 |
| Ceribelli, M; Ferrer, M; Guha, R; Joshi, S; Keller, JM; Kelly, PN; Liu, D; Mathews Griner, LA; Nerle, S; Normant, E; Patel, PR; Sandy, P; Shaffer, AL; Shinn, P; Staudt, LM; Thomas, CJ; Wright, GW; Xiao, W; Yang, Y | 1 |
| Gascoyne, RD; Mottok, A | 1 |
| Campo, E; Ceribelli, M; Chan, WC; Delabie, J; Gascoyne, RD; Huang, DW; Jaffe, ES; Kelly, P; Liu, X; Nakagawa, M; Ott, G; Rimsza, L; Rosenwald, A; Schmitz, R; Shaffer, AL; Staudt, LM; Webster, D; Wright, GW; Xu, W; Yang, Y; Yoo, HM; Young, RM; Yu, X; Zhao, H | 1 |
| Driessen, C; Du, Y; Florea, BI; Krappmann, D; Overkleeft, HS; Schimmack, G; van der Marel, GA; Xin, BT | 1 |
| Atadja, P; Dillon, MP; Fang, D; Feng, L; Fu, X; Gabriel, T; Gao, Z; Gu, J; Guo, H; Huang, Y; Jiang, X; Li, L; Lingel, A; Liu, X; Liu, Y; Mi, Y; Oyang, C; Qi, W; Shultz, MD; Sun, Y; Wang, L; Wang, Y; Yu, Z; Zeng, J; Zhang, C; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, Q; Zhao, K; Zhao, M | 1 |
| Abu Saleh, O; Mahmood, M; Sohail, MR | 1 |
| Fujiwara, Y; Ota, Y; Takeuchi, M; Yoshida, C | 1 |
| Atalay, MA; Koç, N; Sav, H; Unal, E | 1 |
| Aglietta, M; Arese, M; Barra, L; Benelli, R; Bussolino, F; Ghigo, D; Montrucchio, G; Primo, L; Rola-Pleszczynski, MR; Sanavio, F | 1 |
| Vasil'eva, NN | 1 |
| Adamson, RH; Hahn, MA | 1 |
6 review(s) available for triazoles and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
How to Sequence Therapies in Diffuse Large B-Cell Lymphoma Post-CAR-T Cell Failure.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzodiazepines; Consolidation Chemotherapy; Humans; Hydrazines; Immune Checkpoint Inhibitors; Immunoconjugates; Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Radiotherapy; Receptors, Chimeric Antigen; Stem Cell Transplantation; Treatment Failure; Triazoles | 2021 |
A drug profile on selinexor for the treatment of refractory diffuse large B-cell lymphoma.
Topics: Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Triazoles | 2022 |
Selinexor (KTP-330) - a selective inhibitor of nuclear export (SINE): anti-tumor activity in diffuse large B-cell lymphoma (DLBCL).
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Biomarkers, Tumor; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Molecular Targeted Therapy; Triazoles | 2020 |
The nuclear export protein XPO1 - from biology to targeted therapy.
Topics: Antineoplastic Agents; Cell Line, Tumor; Dexamethasone; Drug Resistance, Neoplasm; Exportin 1 Protein; Hematologic Neoplasms; Humans; Hydrazines; Karyopherins; Lymphoma, Large B-Cell, Diffuse; Molecular Targeted Therapy; Receptors, Cytoplasmic and Nuclear; Triazoles | 2021 |
Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Topics: Adoptive Transfer; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Humans; Hydrazines; Immunoconjugates; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Triazoles | 2020 |
FDA Approval Summary: Selinexor for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Topics: Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Multicenter Studies as Topic; Neutropenia; Treatment Outcome; Triazoles | 2021 |
4 trial(s) available for triazoles and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study.
Topics: Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Triazoles | 2022 |
Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study.
Topics: Adenine; Adult; Humans; Hydrazines; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Piperidines; Pyrazoles; Pyrimidines; Triazoles | 2022 |
Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Exportin 1 Protein; Female; Humans; Hydrazines; Karyopherins; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Receptors, Cytoplasmic and Nuclear; Triazoles | 2020 |
Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study.
Topics: Age Factors; Aged; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome; Triazoles | 2021 |
21 other study(ies) available for triazoles and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Treatment Outcome; Triazoles | 2022 |
Selective inhibitors of nuclear export in aggressive B-cell lymphomas.
Topics: Active Transport, Cell Nucleus; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Triazoles | 2020 |
Selinexor for relapsed or refractory diffuse large B-cell lymphoma: examining the artifact.
Topics: Artifacts; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Triazoles | 2020 |
Selinexor for relapsed or refractory diffuse large B-cell lymphoma: examining the artifact - Authors' reply.
Topics: Artifacts; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Triazoles | 2020 |
Selinexor population pharmacokinetic and exposure-response analyses to support dose optimization in patients with diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clinical Studies as Topic; Female; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Treatment Outcome; Triazoles; Young Adult | 2021 |
The positive effect of deferasirox on erythropoiesis in a patient with a dual diagnosis of myelofibrosis and diffuse large B-cell lymphoma.
Topics: Aged; Benzoates; Bone Marrow; Deferasirox; Erythropoiesis; Female; Humans; Image-Guided Biopsy; Immunohistochemistry; Iron Chelating Agents; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Positron-Emission Tomography; Primary Myelofibrosis; Triazoles | 2017 |
Promising activity of selinexor in the treatment of a patient with refractory diffuse large B-cell lymphoma and central nervous system involvement.
Topics: Antineoplastic Agents; Central Nervous System Neoplasms; Compassionate Use Trials; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Middle Aged; Salvage Therapy; Triazoles | 2018 |
Selective inhibitors of nuclear export for the treatment of non-Hodgkin's lymphomas.
Topics: Acrylates; Active Transport, Cell Nucleus; Animals; Exportin 1 Protein; Humans; Karyopherins; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mice; Mice, SCID; Receptors, Cytoplasmic and Nuclear; Treatment Outcome; Triazoles; Tumor Cells, Cultured; Waldenstrom Macroglobulinemia; Xenograft Model Antitumor Assays | 2013 |
Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.
Topics: Azepines; Cell Cycle Proteins; DNA-Binding Proteins; Enhancer Elements, Genetic; Genes, myc; Humans; Lymphoma, Large B-Cell, Diffuse; Nuclear Proteins; Promoter Regions, Genetic; Proto-Oncogene Proteins c-bcl-6; Trans-Activators; Transcription Factors; Transcription, Genetic; Triazoles | 2013 |
Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma.
Topics: Animals; Apoptosis; Azepines; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Proto-Oncogene Proteins c-myc; Signal Transduction; Treatment Outcome; Triazoles; Xenograft Model Antitumor Assays | 2015 |
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors.
Topics: Adenine; Animals; Azepines; Cell Cycle Proteins; Cell Death; Cell Line, Tumor; Cell Survival; Drug Synergism; Humans; I-kappa B Kinase; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, SCID; Nuclear Proteins; Piperidines; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Pyrazoles; Pyrimidines; Signal Transduction; Transcription Factors; Triazoles; Xenograft Model Antitumor Assays | 2014 |
Bromodomain inhibition in diffuse large B-cell lymphoma--giving MYC a brake.
Topics: Animals; Azepines; Cell Proliferation; Humans; Lymphoma, Large B-Cell, Diffuse; Proto-Oncogene Proteins c-myc; Triazoles | 2015 |
Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis Regulatory Proteins; B-Cell CLL-Lymphoma 10 Protein; B-Lymphocytes; Baculoviral IAP Repeat-Containing 3 Protein; Bridged Bicyclo Compounds, Heterocyclic; CARD Signaling Adaptor Proteins; Caspases; Cell Line, Tumor; CRISPR-Cas Systems; Dipeptides; Enzyme Activation; Gene Dosage; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Guanylate Cyclase; Humans; I-kappa B Kinase; Indoles; Inhibitor of Apoptosis Proteins; Intracellular Signaling Peptides and Proteins; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Inbred NOD; Mice, SCID; Mitochondrial Proteins; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein; Multiprotein Complexes; Neoplasm Proteins; NF-kappa B; Protein Processing, Post-Translational; Receptors, Antigen, B-Cell; Triazoles; Ubiquitin-Protein Ligases; Ubiquitination; Xenograft Model Antitumor Assays | 2016 |
Development of new Malt1 inhibitors and probes.
Topics: Carbamates; Caspase Inhibitors; Caspases; Cell Line, Tumor; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Jurkat Cells; Lymphoma, Large B-Cell, Diffuse; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein; Neoplasm Proteins; Triazoles | 2016 |
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Crystallography, X-Ray; Dogs; Female; Haplorhini; Histones; Humans; Lymphoma, Large B-Cell, Diffuse; Lysine; Male; Methylation; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Docking Simulation; Polycomb Repressive Complex 2; Rats; Sulfones; Triazoles | 2017 |
Hypokalemia and Hypertension Associated with Supratherapeutic Posaconazole Levels.
Topics: Adult; Antifungal Agents; Histoplasmosis; Humans; Hypertension; Hypokalemia; Lymphoma, Large B-Cell, Diffuse; Male; Mycoses; Triazoles | 2017 |
Deep skin infection of Scedosporium apiospermum in a patient with refractory idiopathic thrombocytopenic purpura.
Topics: Antifungal Agents; Female; Humans; Immunocompromised Host; Lymphangitis; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Mycetoma; Purpura, Thrombocytopenic, Idiopathic; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2011 |
[The importance of bronchoalveolar lavage sample for galactomannan, 1,3-ß-d-glucan and PCR tests].
Topics: Antifungal Agents; beta-Glucans; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; Cystic Fibrosis; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lymphoma, Large B-Cell, Diffuse; Male; Mannans; Pyrimidines; Real-Time Polymerase Chain Reaction; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.
Topics: Aged; Animals; Azepines; Base Sequence; Cell Line; Chemotaxis; Choriocarcinoma; Collagen; Culture Media, Conditioned; Cytokines; Dogs; Drug Combinations; Endothelium, Vascular; Female; Growth Substances; Humans; Interleukin-1; Laminin; Lymphoma, Large B-Cell, Diffuse; Macrophages; Male; Mice; Mice, Inbred DBA; Molecular Sequence Data; Neoplasm Proteins; Neovascularization, Pathologic; Platelet Activating Factor; Platelet Membrane Glycoproteins; Proteoglycans; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sarcoma, Kaposi; Skin Neoplasms; Thrombin; Triazoles; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Umbilical Veins; Uterine Neoplasms | 1995 |
[Morphologic characteristics of spontaneous tumors and leukoses in 1st generation C47B1XCBA hybrid mice].
Topics: Adenoma; Animals; Carcinogens; Carcinoma, Hepatocellular; Leukemia, Experimental; Liver; Liver Neoplasms; Lung; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Mice; Neoplasms, Experimental; Triazoles | 1969 |
Pharmacology of 3,5-diamino-1,24-triazole (guanazole). 1. Antitumor activity of guanazole.
Topics: Amines; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cyclophosphamide; Cytarabine; Depression, Chemical; Female; Hydroxyurea; In Vitro Techniques; Leukemia L1210; Leukemia, Experimental; Lymphoma, Large B-Cell, Diffuse; Male; Mast-Cell Sarcoma; Methotrexate; Mice; Neoplasms, Experimental; Nitrosourea Compounds; Plasmacytoma; Structure-Activity Relationship; Triazoles | 1972 |